Severe Brief Resolved Unexplained Event in a Newborn Infant in Association with Maternal Sertralin Treatment during Pregnancy
Background: Selective serotonin reuptake inhibitors are a very common choice of antidepressive drug-therapy during pregnancy. In up to 30% of cases, they have been found to cause neonatal abstinence syndrome in newborn infants. Although often both time-limiting and self-limiting, severe symptoms of...
Main Authors: | Mirjam Pocivalnik, Manfred Danda, Berndt Urlesberger, Wolfgang Raith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Medicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2305-6320/5/4/113 |
Similar Items
-
GASTROESOPHAGEAL REFLUX DISEASE IN INFANTS WHO PRESENTED BRIEF RESOLVED UNEXPLAINED EVENT (BRUE)
by: Maria Angela BELLOMO-BRANDÃO, et al.
Published: (2021-12-01) -
Effects of the COVID-19 Pandemic on Brief Resolved Unexplained Events (BRUEs) in Children: A Comparative Analysis of Pre-Pandemic and Pandemic Periods
by: Luana Nosetti, et al.
Published: (2024-03-01) -
Retrospective application of brief resolved unexplained event (BRUE) criteria on infants admitted with ALTE or suspected sepsis: a 5-year analysis in a single tertiary center in Western Saudi Arabia
by: Wallaa Abdulraouf Garout, et al.
Published: (2021-12-01) -
Necessity of Electroencephalography in High-risk Brief Resolved Unexplained Event
by: Hepsen Mine Serin, et al.
Published: (2019-12-01) -
Apparent Life-Threatening Events (ALTE): Italian guidelines
by: Raffaele Piumelli, et al.
Published: (2017-12-01)